European Association of Urology

SHERPA: Unknown

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Fleisher
    Fleisher

Groups

  1. Department of Medicine (10)
  2. Genitourinary Oncology Service (10)
  3. Solid Tumor Oncology Division (10)
Search Within
  1. "Genitourinary Oncology Service"
Formats
  1. Meeting Abstract (10)
Groups
  1. Department of Medicine (10)
  2. Genitourinary Oncology Service (10)
  3. Solid Tumor Oncology Division (10)
People
  1. Robert Motzer (8)
  2. Howard Scher (2)
  3. Aseem Anand (1)
  4. Martin Fleisher (1)
Years
  1. 2012 (1)
  2. 2011 (4)
  3. 2009 (2)
  4. 2008 (1)
  5. 2007 (2)
Publications
  1. European Urology, Supplements (10)

Results (10)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Updated results of the phase 3 AXIS trial: Axitinib vs sorafenib as second-line therapy for metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Escudier, B.; Rini, B. I.; Hutson, T. E.; Gore, M.; Oudard, S.; Tarazi, J.; Rosbrook, B.; Williams, J. A.; Kim, S.; Motzer, R. J.
    European Urology, Supplements (2012)

    Fulltext@MSK | Save
  • Dynamic tumor modelling of the record-1 phase III trial of everolimus quantifies relationship between dose and tumor growth in metastatic renal cell carcinoma
    Meeting Abstract

    Stein, A.; Wang, W.; Carter, A.; Chiparus, O.; Hollaender, N.; Motzer, R.; Sarr, C.
    European Urology, Supplements (2011)

    Fulltext@MSK | Save
  • Everolimus in patients with metastatic renal cell carcinoma: Subgroup analysis of patients with a reduction in tumor burden enrolled in a randomized, placebo-controlled, phase II trial
    Meeting Abstract

    Oudard, S.; Escudier, B.; Hutson, T.; Porta, C.; Bracarda, S.; Grünwald, V.; Thompson, J.; Figlin, R.; Calvo, E.; Kpamegan, E.; more...
    European Urology, Supplements (2011)

    Fulltext@MSK | Save
  • Long-term efficacy results from the phase 1-2 study of MDV3100 in pre-and post-docetaxel advanced prostate cancer
    Meeting Abstract

    Higano, C.; Beer, T.; Yu, E.; Taplin, M. E.; Efstathiou, E.; Anand, A.; Hirmand, M.; Fleisher, M.; Scher, H.
    European Urology, Supplements (2011)

    Fulltext@MSK | Save
  • Abiraterone acetate plus low-dose prednisone has a favorable safety profile in metastatic castration-resistant prostate cancer progressing after docetaxel-based chemotherapy: Results from COU-AA-301, a randomized, double-blind, placebo-controlled, phase III study
    Meeting Abstract

    Fizazi, K.; de Bono, J.; Haqq, C.; Logothetis, C. C.; Jones, R. J.; Chi, K.; Kheoh, T.; Molina, A.; Scher, H.
    European Urology, Supplements (2011)

    Fulltext@MSK | Save
  • Overall survival with sunitinib versus interferon-alfa (IFN-square) as first-line treatment for metastatic renal cell carcinoma (MRCC)
    Meeting Abstract

    Szczylik, C.; Negrier, S.; Oudard, S.; Figlin, R. A.; Hutson, T. E.; Tomczak, P.; Michaelson, M. D.; Bukowski, R. M.; Huang, X.; Kim, S. T.; more...
    European Urology, Supplements (2009)

    Fulltext@MSK | Save
  • Updated data from a phase 3 trial of everolimus (Rad001) versus placebo in patients with metastatic renal cell carcinoma
    Meeting Abstract

    Kay, A.; Motzer, R. J.; Figlin, R. A.; Escudier, B.; Oudard, S.; Porta, C.; Hutson, T. E.; Bracarda, S.; Hollaender, N.; Urbanowitz, G.; more...
    European Urology, Supplements (2009)

    Fulltext@MSK | Save
  • Sunitinib as first-line treatment for metastatic renal cell carcinoma (MRCC): Updated results and analysis of prognostic factors from a phase III randomised trial
    Meeting Abstract

    Oudard, S.; Motzer, R. J.; Michaelson, M. D.; Hutson, T. E.; Tomczak, P.; Bukowski, R. M.; Rixie, O.; Negrier, S.; Kim, S. T.; Chen, J.; more...
    European Urology, Supplements (2008)

    Fulltext@MSK | Save
  • Phase III randomized trial of sunitinib malate versus interferon-alfa as first-line systemic therapy for patients with metastatic renal cell carcinoma
    Meeting Abstract

    Rixe, O.; Hutson, T. E.; Tomczak, P.; Michaelson, M. D.; Bukowski, R. M.; Oudard, S.; Negrier, S.; Kim, S. T.; Chen, I.; Figlin, R. A.; more...
    European Urology, Supplements (2007)

    Fulltext@MSK | Save
  • Effects of sunitinib versus interferon-alfa in health-related quality of life in patients with metastatic renal cell carcinoma (MRCC): Results from a randomized multinational phase III trial
    Meeting Abstract

    Cello, D.; Li, J.; Cappelleri, J. C.; Bushmakin, A.; Kim, S. T.; Chen, I.; Motzer, R. J.
    European Urology, Supplements (2007)

    Fulltext@MSK | Save

    • European Association of Urology – authorized name for: